BIOSINO BIO-TEC (08247) released their annual performance report, showing a net loss of 51.142 million yuan, an increase of 20.24% compared to the previous year.

date
21:08 31/03/2026
avatar
GMT Eight
North Control Biotechnology (08247) announced its annual performance for the year ended December 31, 2025. The group achieved an operating income of 184.3 million yuan, a decrease of 30% year-on-year; the net loss attributable to the owners of the parent company was 51.142 million yuan, an increase of 20.24% year-on-year; the loss per share was 0.353 yuan.
BIOSINO BIO-TEC (08247) announced its annual performance for the year ending December 31, 2025. The group achieved an operating income of 184.3 million RMB, a year-on-year decrease of 30%. The loss attributable to equity holders of the parent company was 51.142 million RMB, an increase of 20.24% compared to the previous year. The loss per share was 0.353 RMB.